Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 55,178Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Zoetis Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2335492

Filing Date : 1999-06-14

Strength per Unit : 3.6 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2019-06-14

Date Granted : 2005-05-17

blank

02

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2733359

Filing Date : 2009-08-10

Strength per Unit : 3.6 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2029-08-10

Date Granted : 2014-08-05

blank

03

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2335492

Filing Date : 1999-06-14

Strength per Unit : 16 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2019-06-14

Date Granted : 2005-05-17

blank

04

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2733359

Filing Date : 2009-08-10

Strength per Unit : 16 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2029-08-10

Date Granted : 2014-08-05

blank

05

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2733359

Filing Date : 2009-08-10

Strength per Unit : 5.4 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2029-08-10

Date Granted : 2014-08-05

blank

06

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 2335492

Filing Date : 1999-06-14

Strength per Unit : 5.4 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2019-06-14

Date Granted : 2005-05-17

blank

07

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 3127621

Filing Date : 2020-02-19

Strength per Unit : 3.6mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 1940-02-19

Date Granted : 2024-05-14

blank

08

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 3127621

Filing Date : 2020-02-19

Strength per Unit : 5.4mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 1940-02-19

Date Granted : 2024-05-14

blank

09

arrow
Peptide Process CMC
Not Confirmed
arrow
Peptide Process CMC
Not Confirmed

Oclacitinib Maleate

Brand Name : APOQUEL

Patent Number : 3127621

Filing Date : 2020-02-19

Strength per Unit : 16mg

Dosage Form : TABLET (CHEWABLE)

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 1940-02-19

Date Granted : 2024-05-14

blank